December 09, 2024
A New York federal judge on Friday upheld an injunction blocking Quincy Bioscience Holding Co. Inc. nationally from making claims that its supplement Prevagen can treat memory problems.
March 12, 2024
A New York federal jury said some statements made by Quincy Bioscience about its memory booster Prevagen were misleading to consumers but found that most statements about the supplement were made on solid grounds.
July 25, 2019
A Federal Trade Commission suit alleging Quincy Bioscience falsely advertised the effectiveness of its memory boosting supplement Prevagen can go forward after a New York federal judge rejected the company's argument that not enough of the FTC's commissioners voted to authorize the suit.
September 29, 2017
A New York federal judge on Thursday zapped a Federal Trade Commission suit targeting a jellyfish-protein supplement, saying the FTC hasn't shown that the popular supplement's purported cognitive benefits are bogus.
June 01, 2017
The Judicial Panel on Multidistrict Litigation has shot down a dietary supplement maker’s attempt to centralize four cases brought in New York, New Jersey and California accusing it of falsely advertising the cognitive benefits of a jellyfish protein in its memory booster Prevagen.
April 06, 2017
A dietary supplement maker told a New York federal court Thursday that it never made any false advertisements touting the cognitive benefits of a jellyfish protein, as it was allowed to select results from a subgroup of study participants.
January 09, 2017
The Federal Trade Commission and the New York Attorney General on Monday sued a prominent dietary supplement maker over a yearslong campaign of allegedly false advertising via major media outlets and national retailers about the cognitive benefits of a jellyfish protein.